In this study we examined the release kinetics of cTnT and cTnI using an in vitro model of NVCM and compared it with data from a model of anthracycline-induced cardiomyopathy in vivo. With 3 uM daunorubicin, the relative increase of AUC of cTnT and cTnI was 2.4 and 5.3-fold higher than the increase of LDH activity, respectively.